NasdaqGM:IIN

Stock Analysis Report

Executive Summary

IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally.


Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

Share Price & News

How has IntriCon's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: IIN's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

7.3%

IIN

-1.6%

US Medical Equipment

-2.6%

US Market


1 Year Return

-50.1%

IIN

-5.2%

US Medical Equipment

-13.3%

US Market

Return vs Industry: IIN underperformed the US Medical Equipment industry which returned -7.7% over the past year.

Return vs Market: IIN underperformed the US Market which returned -15.9% over the past year.


Shareholder returns

IINIndustryMarket
7 Day7.3%-1.6%-2.6%
30 Day-10.8%-10.2%-15.2%
90 Day-28.9%-17.5%-22.2%
1 Year-50.1%-50.1%-4.4%-5.2%-11.5%-13.3%
3 Year39.6%39.6%45.4%41.5%13.2%5.7%
5 Year60.1%60.1%75.2%57.1%31.8%17.2%

Price Volatility Vs. Market

How volatile is IntriCon's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is IntriCon undervalued compared to its fair value and its price relative to the market?

1.2x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: IIN ($12.42) is trading above our estimate of fair value ($9.35)

Significantly Below Fair Value: IIN is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: IIN is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.

PE vs Market: IIN is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate IIN's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: IIN is good value based on its PB Ratio (1.2x) compared to the US Medical Equipment industry average (2.9x).


Next Steps

Future Growth

How is IntriCon forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

82.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: IIN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.7%).

Earnings vs Market: IIN is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: IIN's is expected to become profitable in the next 3 years.

Revenue vs Market: IIN's revenue (7.3% per year) is forecast to grow faster than the US market (7% per year).

High Growth Revenue: IIN's revenue (7.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if IIN's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has IntriCon performed over the past 5 years?

-2.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: IIN is currently unprofitable.

Growing Profit Margin: IIN is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: IIN is unprofitable, and losses have increased over the past 5 years at a rate of -2.1% per year.

Accelerating Growth: Unable to compare IIN's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IIN is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1%).


Return on Equity

High ROE: IIN has a negative Return on Equity (-2.28%), as it is currently unprofitable.


Next Steps

Financial Health

How is IntriCon's financial position?


Financial Position Analysis

Short Term Liabilities: IIN's short term assets ($70.3M) exceed its short term liabilities ($16.9M).

Long Term Liabilities: IIN's short term assets ($70.3M) exceed its long term liabilities ($6.2M).


Debt to Equity History and Analysis

Debt Level: IIN is debt free.

Reducing Debt: IIN has no debt compared to 5 years ago when its debt to equity ratio was 40.5%.

Debt Coverage: IIN has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: IIN has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is IntriCon's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate IIN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate IIN's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if IIN's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IIN's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IIN's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

21.6yrs

Average management tenure


CEO

Mark Gorder (72yo)

19s

Tenure

US$675,982

Compensation

Mr. Mark S. Gorder has been the Chief Executive Officer and President of Intricon Corp., an affiliate of IntriCon Tibbetts Corporation since April 2001. He has been a Director of Intricon Corp., since Janu ...


CEO Compensation Analysis

Compensation vs Market: Mark's total compensation ($USD675.98K) is about average for companies of similar size in the US market ($USD626.39K).

Compensation vs Earnings: Mark's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Mark Gorder
CEO, President & Director19yrsUS$675.98k3.02% $3.3m
J. Longval
Executive VP13.75yrsUS$439.79k0.42% $460.5k
Michael Geraci
Senior Vice President of Sales & Marketing25.25yrsUS$417.14k0.41% $452.6k
Dennis Gonsior
Senior Vice President of Global Operations24.25yrsUS$398.77k0.61% $669.5k
Cari Sather
Director of Human Resourcesno datano datano data

21.6yrs

Average Tenure

60yo

Average Age

Experienced Management: IIN's management team is seasoned and experienced (21.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Mark Gorder
CEO, President & Director19yrsUS$675.98k3.02% $3.3m
Nicholas Giordano
Independent Director19.33yrsUS$146.00k0.88% $963.0k
Raymond Huggenberger
Independent Director0.92yrUS$108.67kno data
Robert Masucci
Independent Director18.17yrsUS$141.00k0.82% $897.0k
Philip Smith
Independent Chairman of the Board0.92yrUS$166.33k0.0097% $10.6k
Philip Seamon
Director Emeritus3.33yrsUS$104.00kno data
Heather Rider
Director0.083yrno datano data

3.3yrs

Average Tenure

71yo

Average Age

Experienced Board: IIN's board of directors are considered experienced (3.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.1%.


Top Shareholders

Company Information

IntriCon Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: IntriCon Corporation
  • Ticker: IIN
  • Exchange: NasdaqGM
  • Founded: 1930
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$109.723m
  • Shares outstanding: 8.81m
  • Website: https://www.intricon.com

Number of Employees


Location

  • IntriCon Corporation
  • 1260 Red Fox Road
  • Arden Hills
  • Minnesota
  • 55112
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IINNasdaqGM (Nasdaq Global Market)YesCommon SharesUSUSDJan 1968
SLJDB (Deutsche Boerse AG)YesCommon SharesDEEURJan 1968

Biography

IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical biotelemetry devices, hearing healthcare, and professional audio communication devices markets. The company also provides medical and micro coils for pacemaker programming and interventional catheter positioning applications; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers. In addition, it offers professional audio headset products used for emergency response needs in the fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear-and head-worn devices used by performers and support staff in the music and stage performance markets. The company sells its hearing device products, and medical and professional audio communications products directly to hearing instrument manufacturers, distributors, and partnerships; and microphone products to the radio communication and professional audio industries, as well as markets and sells hearing aid devices directly to consumers through direct mail advertising, Internet, and call center. IntriCon Corporation was formerly known as Selas Corporation of America. The company was founded in 1930 and is headquartered in Arden Hills, Minnesota. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/04/07 02:26
End of Day Share Price2020/04/06 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.